Neoplasms

3,817 trials 1,526 recruiting

Filter these 3,817 trials by phase, country and sponsor.

Open in Search →

Phase I/II stUdy of ALoCelyvir in patientS with mEtastaticUveal Melanoma (PULSE-UM) Ended

2024-515032-76-00 mEtastatic Uveal Melanoma 9 2021-11-10
Dose Escalation of DF6002 in Patients With Advanced Solid Tumors, and Expansion in Selected Indications Ended

2023-510511-19-00 Advanced Solid Tumors 7 2021-11-08
Phase 2 study of pembrolizumab and chemotherapy in participants with classical Hodgkin Lymphoma that has just been diagnosed Ended

2022-501615-14-00 Classical Hodgkin Lymphoma 4 2021-11-08
Phase Ib of Cyclophosphamide, Pomalidomide, Dexamethasone and Daratumumab (CPD-DARA) in patients with relapsed/refractory multiple myeloma. … Ended

2024-516945-37-00 Relapsed/ refractory multiple myeloma 2 2021-11-04
The BURAN Study of Buparlisib (AN2025) In Combination with Paclitaxel Compared to Paclitaxel Alone, in Patients with Recurrent or Metastatic… Ended

2024-517251-12-00 Recurrent or metastatic head and neck squamous cell car 5 2021-11-02
A Study Investigating DNA-damage Response Agents in Molecularly Altered Advanced Cancer Ended

2024-515102-12-00 Advanced Cancer Whose Tumours Contain Molecular Alterat 4 2021-11-02
SURVIVAL ANALYSIS AFTER NEOADJUVANT TREATMENT IN RESECTABLE PANCREATIC CANCER WITH RISK FACTORS Ended

2024-519633-35-00 Resectable pancreatic adenocarcinoma with risk factors 6 2021-10-25
PARASTOP - Paracetamol with Strong Opioids Ended

2024-515012-53-00 Metastatic cancer disease 5 2021-10-20
Study to assess the efficacy and safety of alpelisib in combination with olaparib in participants with platinum-resistant or refractory gBRC… Ended

2024-510782-42-00 Platinum-resistant or refractory, high-grade serous ova 5 2021-10-15
Asciminib treatment optimization in ≥ 3rd line CML-CP Ended

2024-511381-36-00 Chronic Myelogenous Leukemia in chronic phase (CML-CP) 5 2021-10-13
Efficacy and safety of obinutuzumab versus rituximab in combination with chemotherapy for adult patients with newly diagnosed CD20-positive … Ended

2024-517389-40-00 acute lymphoblastic leukemia 4 2021-10-06
Adjuvant dendritic cell immunotherapy complementing conventional therapy for pediatric patients with high-grade glioma and diffuse intrinsic… Ended

2024-515295-12-00 High-grade glioma (HGG) 4 2021-10-06
A study to assess the safety and efficacy of AZD7789 in participants with advanced or metastatic solid cancer Ended

2022-502774-17-00 Advanced or metastatic gastric and gastro-esophageal ju 7 2021-10-04
An Open-Label, Phase 2 Trial of Nanatinostat in Combination with Valganciclovir in Patients with Epstein-Barr Virus-Positive (EBV+) Relapsed… Ended

2024-512717-41-00 Epstein-Barr Virus-Positive (EBV+) Relapsed/Refractory 4 2021-10-01
Phase III, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy of pre-surgical HPV9-valente vaccination… Ended

2024-513704-34-00 cervical cancer 5 2021-10-01
Phase 1b Study of Dato-DXd in Combination with Pembrolizumab with or without Platinum Chemotherapy in Advanced or Metastatic Non-Small Cell … Ended

2023-508003-20-00 Non-small cell lung cancer 3 2021-09-27
A Drug Absorption Study of MK-3475A in Participants with Solid Tumors Ended

2023-505340-19-00 Advanced or Metastatic Solid Tumors 3 2021-09-20
A Randomized, Open-Label Trial to Compare Tisotumab Vedotin to Investigator's Choice Chemotherapy in Patients with Cervical Cancer Ended

2023-503813-31-01 Second- or Third-Line Recurrent or Metastatic Cervical 5 2021-09-17
7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors Ended

2023-505284-36-00 Advanced solid tumors 4 2021-09-13
First-in-Human Study of RLY-4008 in Patients With ICC and Other Advanced Solid Tumors Ended

2024-512622-29-00 Cholangiocarcinoma (CCA) and Other Advanced Solid Tumor 7 2021-09-10
Preoperative intraperitoneal chemotherapy in adjuvant hyperthermia adjunctive therapy in advanced gastric cancer with high-risk of peritonea… Ended

2024-516042-18-00 Gastric Carcinoma 10 2021-09-08
A Phase 2 Study Evaluating Futibatinib (TAS-120) Plus Pembrolizumab in the Treatment of Advanced or Metastatic bladder, urethra or pelvis ca… Ended

2024-513760-26-00 Advanced or Metastatic Urothelial Carcinoma 4 2021-09-07
Study to Evaluate the Safety and Efficacy of Treatment with NLM-001 before Standard Chemotherapy plus Zalifrelimab in Patients with Advanced… Ended

2024-518852-22-00 Advanced Pancreatic Cancer 3 2021-09-03
Evaluation of the feasibility of PD L 506 for stereotactic interstitial photodynamic therapy (iPDT) in adult patients with newly diagnosed s… Ended

2023-510024-79-00 Glioblastoma 4 2021-09-03